TENET HEALTHCARE CORP (THC) Stock Fundamental Analysis

NYSE:THC • US88033G4073

242.88 USD
+7.76 (+3.3%)
At close: Mar 3, 2026
242.88 USD
0 (0%)
After Hours: 3/3/2026, 8:04:00 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to THC. THC was compared to 101 industry peers in the Health Care Providers & Services industry. THC has an excellent profitability rating, but there are some minor concerns on its financial health. THC is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

  • In the past year THC was profitable.
  • In the past year THC had a positive cash flow from operations.
  • Each year in the past 5 years THC has been profitable.
  • THC had a positive operating cash flow in each of the past 5 years.
THC Yearly Net Income VS EBIT VS OCF VS FCFTHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

1.2 Ratios

  • THC has a better Return On Assets (4.74%) than 75.25% of its industry peers.
  • THC has a better Return On Equity (33.34%) than 93.07% of its industry peers.
  • THC has a Return On Invested Capital of 11.83%. This is amongst the best in the industry. THC outperforms 86.14% of its industry peers.
  • THC had an Average Return On Invested Capital over the past 3 years of 10.41%. This is in line with the industry average of 9.13%.
  • The 3 year average ROIC (10.41%) for THC is below the current ROIC(11.83%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.74%
ROE 33.34%
ROIC 11.83%
ROA(3y)5.99%
ROA(5y)4.56%
ROE(3y)49.35%
ROE(5y)54.59%
ROIC(3y)10.41%
ROIC(5y)9.48%
THC Yearly ROA, ROE, ROICTHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500 1K

1.3 Margins

  • The Profit Margin of THC (6.60%) is better than 84.16% of its industry peers.
  • THC's Profit Margin has improved in the last couple of years.
  • THC has a Operating Margin of 17.28%. This is amongst the best in the industry. THC outperforms 96.04% of its industry peers.
  • In the last couple of years the Operating Margin of THC has grown nicely.
  • Looking at the Gross Margin, with a value of 82.26%, THC belongs to the top of the industry, outperforming 96.04% of the companies in the same industry.
  • In the last couple of years the Gross Margin of THC has remained more or less at the same level.
Industry RankSector Rank
OM 17.28%
PM (TTM) 6.6%
GM 82.26%
OM growth 3Y10.6%
OM growth 5Y17.74%
PM growth 3Y45.5%
PM growth 5Y23.89%
GM growth 3Y-0.27%
GM growth 5Y-0.2%
THC Yearly Profit, Operating, Gross MarginsTHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so THC is still creating some value.
  • Compared to 1 year ago, THC has less shares outstanding
  • THC has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, THC has an improved debt to assets ratio.
THC Yearly Shares OutstandingTHC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
THC Yearly Total Debt VS Total AssetsTHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

2.2 Solvency

  • An Altman-Z score of 1.96 indicates that THC is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • THC has a Altman-Z score (1.96) which is in line with its industry peers.
  • The Debt to FCF ratio of THC is 5.21, which is a neutral value as it means it would take THC, 5.21 years of fcf income to pay off all of its debts.
  • THC has a better Debt to FCF ratio (5.21) than 62.38% of its industry peers.
  • A Debt/Equity ratio of 3.10 is on the high side and indicates that THC has dependencies on debt financing.
  • THC has a worse Debt to Equity ratio (3.10) than 74.26% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.1
Debt/FCF 5.21
Altman-Z 1.96
ROIC/WACC1.43
WACC8.26%
THC Yearly LT Debt VS Equity VS FCFTHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B

2.3 Liquidity

  • THC has a Current Ratio of 1.76. This is a normal value and indicates that THC is financially healthy and should not expect problems in meeting its short term obligations.
  • THC has a better Current ratio (1.76) than 70.30% of its industry peers.
  • A Quick Ratio of 1.68 indicates that THC should not have too much problems paying its short term obligations.
  • THC has a Quick ratio of 1.68. This is in the better half of the industry: THC outperforms 69.31% of its industry peers.
Industry RankSector Rank
Current Ratio 1.76
Quick Ratio 1.68
THC Yearly Current Assets VS Current LiabilitesTHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 41.01% over the past year.
  • Measured over the past years, THC shows a quite strong growth in Earnings Per Share. The EPS has been growing by 16.26% on average per year.
  • THC shows a small growth in Revenue. In the last year, the Revenue has grown by 3.12%.
  • The Revenue has been growing slightly by 3.85% on average over the past years.
EPS 1Y (TTM)41.01%
EPS 3Y34.93%
EPS 5Y16.26%
EPS Q2Q%36.63%
Revenue 1Y (TTM)3.12%
Revenue growth 3Y3.58%
Revenue growth 5Y3.85%
Sales Q2Q%8.97%

3.2 Future

  • The Earnings Per Share is expected to grow by 2.62% on average over the next years.
  • The Revenue is expected to grow by 3.43% on average over the next years.
EPS Next Y-1.03%
EPS Next 2Y3.47%
EPS Next 3Y6.93%
EPS Next 5Y2.62%
Revenue Next Year3.93%
Revenue Next 2Y3.18%
Revenue Next 3Y3.48%
Revenue Next 5Y3.43%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
THC Yearly Revenue VS EstimatesTHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B 20B 25B
THC Yearly EPS VS EstimatesTHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15 20 25

6

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 14.47, the valuation of THC can be described as correct.
  • Compared to the rest of the industry, the Price/Earnings ratio of THC indicates a rather cheap valuation: THC is cheaper than 85.15% of the companies listed in the same industry.
  • THC's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.83.
  • Based on the Price/Forward Earnings ratio of 14.63, the valuation of THC can be described as correct.
  • Based on the Price/Forward Earnings ratio, THC is valued cheaply inside the industry as 83.17% of the companies are valued more expensively.
  • THC's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 24.95.
Industry RankSector Rank
PE 14.47
Fwd PE 14.63
THC Price Earnings VS Forward Price EarningsTHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • THC's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. THC is cheaper than 86.14% of the companies in the same industry.
  • THC's Price/Free Cash Flow ratio is rather cheap when compared to the industry. THC is cheaper than 87.13% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.44
EV/EBITDA 6.81
THC Per share dataTHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 100 200

4.3 Compensation for Growth

  • THC has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.89
EPS Next 2Y3.47%
EPS Next 3Y6.93%

0

5. Dividend

5.1 Amount

  • No dividends for THC!.
Industry RankSector Rank
Dividend Yield 0%

TENET HEALTHCARE CORP

NYSE:THC (3/3/2026, 8:04:00 PM)

After market: 242.88 0 (0%)

242.88

+7.76 (+3.3%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-11
Earnings (Next)04-27
Inst Owners98.45%
Inst Owner Change-2.1%
Ins Owners0.73%
Ins Owner Change6.19%
Market Cap21.35B
Revenue(TTM)21.31B
Net Income(TTM)1.41B
Analysts81.43
Price Target255.33 (5.13%)
Short Float %3.17%
Short Ratio2.84
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.87%
Min EPS beat(2)10.92%
Max EPS beat(2)14.82%
EPS beat(4)4
Avg EPS beat(4)25.53%
Min EPS beat(4)10.92%
Max EPS beat(4)38.59%
EPS beat(8)8
Avg EPS beat(8)35.38%
EPS beat(12)12
Avg EPS beat(12)33.64%
EPS beat(16)16
Avg EPS beat(16)40.61%
Revenue beat(2)0
Avg Revenue beat(2)-0.14%
Min Revenue beat(2)-0.28%
Max Revenue beat(2)0%
Revenue beat(4)2
Avg Revenue beat(4)0.36%
Min Revenue beat(4)-0.28%
Max Revenue beat(4)1.13%
Revenue beat(8)5
Avg Revenue beat(8)0.39%
Revenue beat(12)8
Avg Revenue beat(12)0.73%
Revenue beat(16)9
Avg Revenue beat(16)0.21%
PT rev (1m)6.73%
PT rev (3m)8.93%
EPS NQ rev (1m)-6.22%
EPS NQ rev (3m)-5.87%
EPS NY rev (1m)0.36%
EPS NY rev (3m)-0.18%
Revenue NQ rev (1m)-0.89%
Revenue NQ rev (3m)-1.02%
Revenue NY rev (1m)-0.33%
Revenue NY rev (3m)-0.27%
Valuation
Industry RankSector Rank
PE 14.47
Fwd PE 14.63
P/S 1
P/FCF 8.44
P/OCF 6.03
P/B 5.06
P/tB N/A
EV/EBITDA 6.81
EPS(TTM)16.78
EY6.91%
EPS(NY)16.61
Fwd EY6.84%
FCF(TTM)28.79
FCFY11.85%
OCF(TTM)40.28
OCFY16.58%
SpS242.46
BVpS48.01
TBVpS-94.73
PEG (NY)N/A
PEG (5Y)0.89
Graham Number134.64
Profitability
Industry RankSector Rank
ROA 4.74%
ROE 33.34%
ROCE 14.6%
ROIC 11.83%
ROICexc 13.35%
ROICexgc 30.47%
OM 17.28%
PM (TTM) 6.6%
GM 82.26%
FCFM 11.87%
ROA(3y)5.99%
ROA(5y)4.56%
ROE(3y)49.35%
ROE(5y)54.59%
ROIC(3y)10.41%
ROIC(5y)9.48%
ROICexc(3y)11.56%
ROICexc(5y)10.42%
ROICexgc(3y)25.7%
ROICexgc(5y)22.87%
ROCE(3y)12.86%
ROCE(5y)11.71%
ROICexgc growth 3Y16.45%
ROICexgc growth 5Y21.31%
ROICexc growth 3Y13.69%
ROICexc growth 5Y19.39%
OM growth 3Y10.6%
OM growth 5Y17.74%
PM growth 3Y45.5%
PM growth 5Y23.89%
GM growth 3Y-0.27%
GM growth 5Y-0.2%
F-Score6
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 3.1
Debt/FCF 5.21
Debt/EBITDA 2.88
Cap/Depr 117.03%
Cap/Sales 4.74%
Interest Coverage 4.26
Cash Conversion 77.89%
Profit Quality 179.82%
Current Ratio 1.76
Quick Ratio 1.68
Altman-Z 1.96
F-Score6
WACC8.26%
ROIC/WACC1.43
Cap/Depr(3y)105.72%
Cap/Depr(5y)96.95%
Cap/Sales(3y)4.3%
Cap/Sales(5y)4.05%
Profit Quality(3y)160.11%
Profit Quality(5y)131.6%
High Growth Momentum
Growth
EPS 1Y (TTM)41.01%
EPS 3Y34.93%
EPS 5Y16.26%
EPS Q2Q%36.63%
EPS Next Y-1.03%
EPS Next 2Y3.47%
EPS Next 3Y6.93%
EPS Next 5Y2.62%
Revenue 1Y (TTM)3.12%
Revenue growth 3Y3.58%
Revenue growth 5Y3.85%
Sales Q2Q%8.97%
Revenue Next Year3.93%
Revenue Next 2Y3.18%
Revenue Next 3Y3.48%
Revenue Next 5Y3.43%
EBIT growth 1Y14.49%
EBIT growth 3Y14.57%
EBIT growth 5Y22.28%
EBIT Next Year24.61%
EBIT Next 3Y10.68%
EBIT Next 5Y6.81%
FCF growth 1Y126.7%
FCF growth 3Y99.01%
FCF growth 5Y-2.47%
OCF growth 1Y72.94%
OCF growth 3Y48.41%
OCF growth 5Y0.77%

TENET HEALTHCARE CORP / THC FAQ

What is the ChartMill fundamental rating of TENET HEALTHCARE CORP (THC) stock?

ChartMill assigns a fundamental rating of 6 / 10 to THC.


What is the valuation status for THC stock?

ChartMill assigns a valuation rating of 6 / 10 to TENET HEALTHCARE CORP (THC). This can be considered as Fairly Valued.


Can you provide the profitability details for TENET HEALTHCARE CORP?

TENET HEALTHCARE CORP (THC) has a profitability rating of 9 / 10.


What is the valuation of TENET HEALTHCARE CORP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for TENET HEALTHCARE CORP (THC) is 14.47 and the Price/Book (PB) ratio is 5.06.


Can you provide the expected EPS growth for THC stock?

The Earnings per Share (EPS) of TENET HEALTHCARE CORP (THC) is expected to decline by -1.03% in the next year.